Disclose your full medication list: If you're on insulin, sulfonylureas, metformin, or any other diabetes medications - or any medication with a potential GLP-1 interaction - disclose it fully at intake
Seymour Island, Antarctic Peninsula)
That puts the earliest realistic decision window in late 2027 to the first half of 2028
Microdosing is entirely off-label, as there is no set dosing for it
Comparing Retatrutide to Available Alternatives Several weight loss medications currently hold Health Canada approval, offering comparison points for understanding where Retatrutide fits in the treatment landscape
Basic laboratory evaluation is appropriate for patients with persistent or severe fatigue and should include complete blood count, comprehensive metabolic panel, thyroid-stimulating hormone, ferritin/iron studies, and vitamin B12 and vitamin D levels